| GENE_SYMBOL |
DRUG_NAME |
Ki (nM) |
IC50 (nM) |
Kd (nM) |
EC50 (nM) |
Potency (nM) |
AC50 (nM) |
Datasource |
| SELE |
5-[(2S,4S)-2-[[(2S,3R)-1-ethoxy-1-oxo-3-[(2R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxybutan-2-yl]carbamoyl]-4-hydroxypyrrolidin-1-yl]-5-oxopentanoic acid |
NA |
1000000 |
NA |
NA |
NA |
NA |
TTD |
| SELE |
5-{(2S,4R)-2-[(1S,2R)-1-Ethoxycarbonyl-2-((2R,5S,6S)-3,4,5-trihydroxy-6-methyl-tetrahydro-pyran-2-yloxy)-propylcarbamoyl]-4-hydroxy-pyrrolidin-1-yl}-5-oxo-pentanoic acid anion |
NA |
300000 |
NA |
NA |
NA |
NA |
BindingDB |
| SELE |
5-[(2S,4R)-2-[[(2S,3R)-1-ethoxy-1-oxo-3-[(2R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxybutan-2-yl]carbamoyl]-4-hydroxypyrrolidin-1-yl]-5-oxopentanoic acid |
NA |
300000 |
NA |
NA |
NA |
NA |
TTD |
| SELE |
5-{(2R,4R)-2-[(1S,2R)-1-Ethoxycarbonyl-2-((2R,5S,6S)-3,4,5-trihydroxy-6-methyl-tetrahydro-pyran-2-yloxy)-propylcarbamoyl]-4-hydroxy-pyrrolidin-1-yl}-5-oxo-pentanoic acid anion |
NA |
3000000 |
NA |
NA |
NA |
NA |
BindingDB |
| SELE |
5-[(2R,4R)-2-[[(2S,3R)-1-ethoxy-1-oxo-3-[(2R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxybutan-2-yl]carbamoyl]-4-hydroxypyrrolidin-1-yl]-5-oxopentanoic acid |
NA |
3000000 |
NA |
NA |
NA |
NA |
TTD |
| SELE |
5-{(2S,3R,4S)-3,4-Dihydroxy-2-[(1R,2R)-2-((2R,5S,6S)-3,4,5-trihydroxy-6-methyl-tetrahydro-pyran-2-yloxy)-cyclohexylcarbamoyl]-pyrrolidin-1-yl}-5-oxo-pentanoic acid anion |
NA |
5000000 |
NA |
NA |
NA |
NA |
BindingDB |
| SELE |
5-[(2S,3R,4S)-3,4-dihydroxy-2-[[(1R,2R)-2-[(2R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxycyclohexyl]carbamoyl]pyrrolidin-1-yl]-5-oxopentanoic acid |
NA |
5000000 |
NA |
NA |
NA |
NA |
TTD |
| SELE |
4-[(1-{[(2S,3R)-1-ethoxy-1-oxo-3-{[(2R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}butan-2-yl]carbamoyl}-2-hydroxy-1-(hydroxymethyl)ethyl)carbamoyl]butanoate |
NA |
900000 |
NA |
NA |
NA |
NA |
BindingDB |
| SELE |
5-[[1-[[(2S,3R)-1-ethoxy-1-oxo-3-[(2R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxybutan-2-yl]amino]-3-hydroxy-2-(hydroxymethyl)-1-oxopropan-2-yl]amino]-5-oxopentanoic acid |
NA |
900000 |
NA |
NA |
NA |
NA |
TTD |
| SELE |
4-{(1R,2R)-1-[(1S,2R)-1-Ethoxycarbonyl-2-((2R,5S,6S)-3,4,5-trihydroxy-6-methyl-tetrahydro-pyran-2-yloxy)-propylcarbamoyl]-2,3-dihydroxy-propylcarbamoyl}-butyric acid anion |
NA |
500000 |
NA |
NA |
NA |
NA |
BindingDB |
| SELE |
5-[[(2R,3R)-1-[[(2S,3R)-1-ethoxy-1-oxo-3-[(2R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxybutan-2-yl]amino]-3,4-dihydroxy-1-oxobutan-2-yl]amino]-5-oxopentanoic acid |
NA |
500000 |
NA |
NA |
NA |
NA |
TTD |
| SELE |
Rotavirus inhibitor, sialylmimetics 4 |
NA |
700000 |
NA |
NA |
NA |
NA |
BindingDB |
| SELE |
[3,4,5-Trimethoxy-2-(3,4,5-trihydroxy-6-methyl-tetrahydro-pyran-2-yl)-phenyl]-acetic acid |
NA |
1000000 |
NA |
NA |
NA |
NA |
TTD |
| SELE |
4-[4-Methoxy-3-(3,4,5-trihydroxy-6-methyl-tetrahydro-pyran-2-yl)-phenyl]-butyric acid |
NA |
1000000 |
NA |
NA |
NA |
NA |
TTD |
| SELE |
[4-Methoxy-3-(3,4,5-trihydroxy-6-methyl-tetrahydro-pyran-2-yl)-phenyl]-acetic acid |
NA |
1000000 |
NA |
NA |
NA |
NA |
TTD |
| SELE |
1-[4-Methoxy-3-(3,4,5-trihydroxy-tetrahydro-pyran-2-yl)-phenyl]-cyclohexanecarboxylic acid |
NA |
1000000 |
NA |
NA |
NA |
NA |
TTD |
| SELE |
1-[4-Methoxy-3-(3,4,5-trihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yl)-phenyl]-cyclohexanecarboxylic acid |
NA |
1000000 |
NA |
NA |
NA |
NA |
TTD |
| SELE |
5-Acetylamino-2-(3,5-dihydroxy-2-hydroxymethyl-6-N-[2,5-Dihydroxy-6-hydroxymethyl-4-(3,4,5-trihydroxy-6-methyl-tetrahydro-pyran-2-yloxy)-tetrahydro-pyran-3-yl]-acetamide-tetrahydro-pyran-4-yloxy)-4-hydroxy-6-(1,2,3-trihydroxy-propyl)-tetrahydro-pyran-2-carboxylic acid |
NA |
600000 |
NA |
NA |
NA |
NA |
BindingDB |
| SELE |
4-Methylcarbamoyl-4-[(R)-3-(3,4,5-trihydroxy-6-methyl-tetrahydro-pyran-2-yloxy)-2-(2-undecyl-tridecanoylamino)-propionylamino]-butyric acid |
NA |
160000 |
NA |
NA |
NA |
NA |
BindingDB|TTD |
| SELE |
N-Methyl-3-[(R)-2-(2-tetradecyl-hexadecanoylamino)-3-(3,4,5-trihydroxy-6-methyl-tetrahydro-pyran-2-yloxy)-propionylamino]-succinamic acid |
NA |
500000 |
NA |
NA |
NA |
NA |
TTD |